Kevin J. Black @kjbinstl@qoto.org

Research is published via PDF prisons, which discourages self-correction.

Adam Kane and @Bawan propose a solution: "Authors would include a link in their published manuscripts to an updatable website (e.g. a GitHub repository) that could be disseminated in the event of any amendment [...] This would remove a number of frictions that discourage amendments leading to an improved scientific literature and a healthier academic climate."

via https://doi.org/10.1098/rsbl.2022.0463
@academicchatter #OpenScience

Now also with the correct URL:

http://bjoern.brembs.net/2023/02/how-about-paying-extra-for-peer-review/

And another workflow acquisition by one of the big four surveillance publishers:

https://group.springernature.com/gp/group/media/press-releases/springer-nature-acquires-researcher-created-writing-tool/24020648

Soon, there will be no escaping the surveilance...

#openscience #surveillance

New #podcast episode! Dr. Corey Hopkins discusses his career spanning industry and #academia, his #research developing and testing new compounds to treat diseases with unmet medical need, his life outside the lab, and more!

https://www.peoplebehindthescience.com/dr-corey-hopkins/

Thank you for a great conversation,
@Hopkins_Lab!

#chemistry #podcasts #science #STEM #scicomm #drugdiscovery #ScienceMastodon #biology

Power analyses should not be based on the effect you expect but on the smallest effect size of interest. You commonly hear people say power analysis is not possible because you don't know the effect size. But this is a (common) misunderstanding of what you are suposed to do in a power analysis. You plan for the effect you do not want to miss - not for a guess of what it might be. See https://online.ucpress.edu/collabra/article/8/1/33267/120491/Sample-Size-Justification

Stop the peer-review treadmill. I want to get off https://doi.org/10.1038/d41586-023-00403-8

Informative piece on the overburdened peer review system.

Happy to see discussion of preprint review: "Rebeccah Lijek ... directs her reviewing energies to preprints ... She loves being able to consider the science just on its merits, without judging whether a study is original enough to deserve publication by a specific journal. She finds the process more collegial and has made new connections and friends through it."

@admin @Neurogirl1976 @siderea @notes @dramypsyd Found it! https://www.propublica.org/article/unitedhealth-healthcare-insurance-denial-ulcerative-colitis

Yup -- it's true. This client has NO mental health coverage. My billing people say this is increasingly common.

In fact -- it gets worse. As my biller says:

"The only information they would provide is that she has no mental health benefits at all and that if she received treatment prior to the effective date of this coverage it would not be covered for 12 months due to being a pre-existing condition."

The plan is US Health Group (A Unitedhealthcare Company) underwritten by Freedom Life Insurance Company of America. They are formerly known as "UMR" and still appear this way in billing systems and their snail mail address.

Apparently a search of Maryland's ACA (Affordable Care Act) Health Connection website for useful insurance coverage prompts a flurry of texts and calls from random health insurance brokers looking to sell desperate people trash plans not on the state exchange. In this case some high speed sales script reading was involved and the client did not fully understand what was being purchased. This is not a stupid client.

There are so many problems here:

1) The original outrage of no mental health coverage.
2) The possibility that NO PRE-EXISTING CONDITION MIGHT BE COVERED. (I have no reason to assume that statement only applies to mental health pre-existing conditions. I don't know.).
3) That client contact data from Maryland Health Connection government website is available to brokers of possibly shady plans.
4) That United Health is actively supporting and has some ownership in a plan that certainly at least smells like a SCAM, although I'm sure it sold as extreme cut-rate no-frills insurance.

This needs to stop.

#psychology #insurance #mentalhealth #psychiatry #covid #socialwork
#healthadvocacy #aca #apa @psychology @socialwork
@psychotherapists @psychiatry #psychotherapy
#covidisnotover #telehealth
@SuprmomcatCathy @Neurogirl1976 @siderea @notes @dramypsyd
#marylandhealthconnection #marylandaca
#uhc #unitedhealthcare #ushealthgroup #UMR #freedomlifeinsurance

In case you’re coming to Boston for @anpadirect and arrive the day before, consider visiting us for an informal pre-event at the @Brain_Circuits for two exciting talks from leading researchers in the field! 👇👇

@leaddbs @foxmdphd @shansiddiqi @neuromichael @IsaiahNeurology
---
RT @Brain_Circuits
Together with the @BSNNP1880,

the Center for Brain Circuit Therapeutics

is excited to host @ChristosGanos and @LUSCHERC for an evening …
https://twitter.com/Brain_Circuits/status/1620870914232696832

Thought today might be a good one to re-post something I'd put on another social network about #SolomonCarterFuller, often celebrated as the 1st Black psychiatrist, but whose place in #neurology and #neuroscience is underrecognized.

As a med student, Fuller attended a key event in the history of US neuropsychiatry: neurologist S. Weir Mitchell’s address to the AMPA (precursor to APA). Mitchell harshly critiqued the absence of a research program in asylum medicine. Asylums responded by setting up new labs; as autopsies were uncommon in the US compared to Europe, Fuller recognized that this new field presented more open opportunity to him as a Black MD, and came to lead a pathology lab at Westboro Hospital.

Like many US docs then, he sought more training in Europe. He studied German and in 1904 went to Munich, where he worked in Alzheimer's lab alongside Frederic #Lewy. He was treated more equitably there than in the US.

After his return to the US, Auguste D died in 1906 and #Alzheimer presented her case; that year Fuller presented one of the first accounts of neurofibrillary pathology to the AMPA. In 1912 Fuller published the 1st review of #AlzheimersDisease cases (including one of his own, the 9th overall) and the first English translation of Alzheimer's work.

In 1909, Fuller was invited to speak at #ClarkUniversity 20th anniversary; other invitees were a “little-known Viennese neurologist and his Swiss colleague” (Anne Harrington, Mind Fixers)—a turning point in US psychiatry. Fuller took interest in psychoanalysis & maintained correspondence w/ Jung, Meyer & Adler.

Fuller trained a cohort of Black psychiatrists, who mentored others. He led the #BostonUniversity dept of neurology for 5y but underpaid and untitled; when a white assistant prof was named chair ahead of him he went into private practice. His death was commemorated by James B Ayer: https://www.nejm.org/doi/full/10.1056/NEJM195401212500316

In addition to these scientific connections, Fuller enjoyed close ties with other important historical figures. His wife Meta was herself an important sculptor championed by Rodin & they were close with other leaders like W.E.B. DuBois & Paul Robeson.

Neurologists and neuroscientists should celebrate Fuller as our colleagues in #psychiatry do. I recommend Mary Kaplan's lively biography Where My Caravan Has Rested, including an oral history that Fuller dictated to his son, to all. #BlackHistory #BlackHistoryMonth #BlackInNeuro

Officially out now in Journal of Cognitive Neuroscience!
direct.mit.edu/jocn/article/3…

If you're interested in how individual differences in 🧠 brain organization differ across the hemispheres, check it out.

Great work by grad student Diana Perez! 🙌
and collaborators Ally Dworetsky, Rodrigo Braga, & Mark Beeman

Should statistical thresholds for deciding research "significance" be retired?

The reliance on p-value thresholds has contributed to the replication crisis as scientists are often pressured to have ps < 0.05 to be able to publish, and thereby continue their careers in academia.

"We hope that methods sections and data tabulation will be more detailed and nuanced. Authors will emphasize their estimates and the uncertainty in them"

via https://doi.org/10.1038/d41586-019-00857-9
@academicchatter #Science #SciComm

@NeuroSchnell @schoppik @NicoleCRust @brembs

As a reviewing editor, and as scientist and paper author, I have no idea who the “readership” is. Readers of one paper in a journal are extremely unlikely to want to read most papers from the same journal. Scientists read papers, not journals. A journal’s contents is a collection of misfits. There isn’t and there can’t be a coherent theme, as this would have to be so narrowly defined that it would, in essence, be personalised to each reader.